Welcome to the Theriva Biologics Conference Call!

Get ready to dive deep into the world of cancer therapeutics

Rockville, Md., Nov. 03, 2022 (GLOBE NEWSWIRE) — Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, is all set to host a conference call on Thursday, November 10, 2022, at 8:30 a.m. ET. So mark your calendars and get ready to tune in!

What to expect:

This conference call will delve into the operational highlights and financial results of the third quarter of 2022. Get ready to hear about the latest advancements in cancer treatment and the impact it’s having on patients worldwide. The experts at Theriva Biologics will provide insights into their research and development efforts, giving you a behind-the-scenes look at the future of cancer therapeutics.

So grab your favorite cup of coffee, settle into your comfiest chair, and join us for a morning of enlightening discussions and exciting revelations!

How will this affect you?

As a potential future patient, this conference call could provide valuable information about potential new treatment options for cancer. It’s a chance to learn about the cutting-edge therapies being developed by Theriva Biologics and how they could impact your journey towards recovery.

How will this affect the world?

The groundbreaking research and development efforts of companies like Theriva Biologics have the potential to revolutionize the field of oncology. By participating in this conference call, you’re staying informed about the latest advancements in cancer therapeutics and contributing to the global conversation on improving patient outcomes.

In conclusion,

Don’t miss out on this fantastic opportunity to gain valuable insights into the world of cancer therapeutics. Join us for the Theriva Biologics conference call and discover the future of cancer treatment!